Novipel Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Novipel General Information


Developer of a medical technology device designed to provide clinical assessment and diagnosis of female urinary incontinence (UI). The company's device informs women about urinary incontinence and helps in breaking the taboo, enabling women to seek professional help, and make the number of women with urinary incontinence (UI) to shrink.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Nørre Allé 41
  • 2200 Copenhagen
  • Denmark
+45 26 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novipel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 23-Apr-2018 Completed Startup
1. Accelerator/Incubator 06-Feb-2015 Completed Startup
To view Novipel’s complete valuation and funding history, request access »

Novipel Executive Team (3)

Name Title Board Seat Contact Info
Alexander Hennings Founder & Chief Executive Officer
Shamiel Jansen Chief Financial Officer
Diana Durieux CMO
To view Novipel’s complete executive team members history, request access »

Novipel Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Go Grow Accelerator/Incubator Minority 000 0000 000000 0
Danish Tech Challenge Accelerator/Incubator 000 0000 000000 0
To view Novipel’s complete investors history, request access »